VCP Scanner
Stock Screener
Filter stocks with fundamental & technical criteria
Market Themes
Curated industry baskets & thematic leaders
Earnings Hub
Calendar, EPS surprise stats & earnings transcripts
Market News
Real-time market intelligence & AI overviews
Insider Buying
SEC Form 4 corporate insider purchases
LearnAll lessons
Candlestick Patterns44 candles, each on two real charts
Pattern GuidesThe playbooks' setups on real breakouts
GlossaryInvesting terms in plain English
MinerviniVCP SetupsTrend Template
O'NeilCup with HandleFlat BaseDouble BottomCANSLIM Leaders
QullamaggieHigh Tight FlagsFlag BreakoutsEpisodic PivotsMomentum Leaders
KellWedge PopEMA Crossback
LivermorePivotal Points
PatternsFalling Wedge & ChannelBase Breakouts
View All Playbooks...
BreakoutsScanner
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Index & ETFs
SPY vs QQQVTI vs VOOSPY vs IWM
Compare Any Stocks...
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
VisualizeInteractive multi-year financial charts
Watchlist
BreakoutsScanner
WatchlistPricing
Ctrl K
Pricing
ALGS
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Analyze deeply. Research with clarity.

Data updated daily

Product

  • Screener
  • Scanner
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • Pricing
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly market insights — free

© 2026 VCP Scanner
AboutPrivacyTermsRefund Policy
Not financial advice. Do your own research.
ScreenerBreakoutsScannerWatchlist
ALGSAligos Therapeutics, Inc.
$1.30$8M
Overview & Tools
OverviewChart Terminal ↗Visualize
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice History
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Discovery & Screens
Live BreakoutsStock ScreenerOwnership
HomeStocksALGSQuarterly Balance Sheet

Aligos Therapeutics, Inc. (ALGS) Quarterly Balance Sheet

120+ quarters historyFree accessUpdated daily

Aligos Therapeutics, Inc. (ALGS) quarterly balance sheet — complete assets, liabilities & equity history

Income StatementBalance SheetCash FlowRatios

ALGS Balance Sheet

Quarterly statement

ALGS Balance Sheet

Aligos Therapeutics, Inc. (ALGS) balance sheet — 8-year assets, liabilities & shareholders' equity history

AnnualQuarterly
MetricQ3'26Q2'26Q1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23Q1'23Q4'22Q3'22Q2'22Q1'22Q4'21
Total Current Assets34.68M62.13M59.63M82.86M103.44M127.94M143.21M62.14M79.82M99.57M118.06M141.08M74.64M94.24M109.43M133.54M150.09M167.69M195.08M204.42M
Cash & Short-Term Investments31.09M30.38M55.08M77.95M99.1M122.94M137.86M56.94M74.92M94.54M112.74M135.7M70.43M90.84M103.52M125.83M142.3M159.34M183.22M190.73M
Cash Only31.09M30.38M30.15M18.41M41.95M18.66M73.76M37M35.33M45.08M24.15M135.7M70.43M90.83M78.67M81.35M86.44M71.17M104.56M186.82M
Short-Term Investments0024.93M59.54M57.15M104.28M64.1M19.94M39.59M49.46M88.59M0010K24.84M44.48M55.86M88.17M78.66M3.92M
Accounts Receivable027.78M000000000000000000
Days Sales Outstanding-91------------------
Inventory00000000000000000000
Days Inventory Outstanding--------------------
Other Current Assets3.59M3.97M4.55M4.91M4.34M5M5.34M5.2M4.9M5.03M5.33M5.38M4.21M3.4M5.91M7.72M7.79M8.34M11.85M13.69M
Total Non-Current Assets12.51M4.2M4.93M6.72M6.33M6.76M7.49M7.95M8.6M9.24M9.84M10.44M11.21M11.89M12.31M13.15M13.98M14.84M15.39M30.95M
Property, Plant & Equipment12.24M3.44M4.17M4.96M5.62M6.12M6.86M7.33M7.97M8.61M9.21M9.82M10.59M11.26M11.68M12.51M13.32M14.22M14.78M14.97M
Fixed Asset Turnover0.37x7.30x0.62x0.03x0.13x0.15x0.04x0.08x0.15x0.12x0.10x0.26x0.30x0.60x0.23x0.27x0.30x0.25x0.17x0.03x
Goodwill00000000000000000000
Intangible Assets00000000000000000000
Long-Term Investments000000000000000000015.11M
Other Non-Current Assets268K759K759K715K713K640K632K627K635K631K625K625K623K624K632K634K653K616K616K866K
Total Assets47.19M66.33M64.56M89.58M109.76M134.71M150.7M70.09M88.43M108.81M127.9M151.53M85.85M106.13M121.74M146.69M164.07M182.52M210.47M235.37M
Asset Turnover0.05x0.42x0.04x0.00x0.01x0.01x0.00x0.01x0.01x0.01x0.01x0.02x0.03x0.06x0.02x0.02x0.02x0.02x0.01x0.00x
Asset Growth %-57.01%-50.76%-57.16%27.8%24.13%23.8%17.82%-53.74%3%2.53%5.06%3.3%-47.67%-41.85%-42.16%-37.68%-37.63%-13.85%-10.26%-11.28%
Total Current Liabilities19.6M28.34M23.32M21.23M21.99M20.27M18.95M21.74M20.96M23.56M18.88M23.91M22.47M27.23M28.08M33.13M30.54M31.65M41.36M38.96M
Accounts Payable3.21M6.43M7.64M3.98M4.65M3.94M4.46M2.57M2.74M6.82M2.84M2.52M2.94M3.24M2.82M4.74M2.93M2.76M3.75M3.02M
Days Payables Outstanding---1.55K-1.48K---720.62----------
Short-Term Debt003.69M3.73M0000000000000000
Deferred Revenue (Current)0000168K579K0151K655K1.33M721K1.31M3.95M6.95M7.03M9.21M10.72M13.13M15.07M7.64M
Other Current Liabilities04.74M7.77M6.06M5.28M4.42M3.45M6.39M4.41M3.6M3.06M6.67M4.09M3.16M3.13M6.36M5.16M3.33M3.73M6.61M
Current Ratio1.77x2.19x2.56x3.90x4.70x6.31x7.56x2.86x3.81x4.23x6.25x5.90x3.32x3.46x3.90x4.03x4.91x5.30x4.72x5.25x
Quick Ratio1.77x2.19x2.56x3.90x4.70x6.31x7.56x2.86x3.81x4.23x6.25x5.90x3.32x3.46x3.90x4.03x4.91x5.30x4.72x5.25x
Cash Conversion Cycle--------------------
Total Non-Current Liabilities16.28M288K9.45M14.8M15.94M12.57M15.31M77.33M17.37M18.02M49.23M35.54M8.56M9.27M8.91M9.66M11.52M13.89M16.23M11.68M
Long-Term Debt00000000000000000000
Capital Lease Obligations10.66M288K659K1.52M2.5M3.34M4.39M4.92M5.73M6.48M7.21M7.9M8.52M9.18M8.82M9.43M9.83M10.5M11.08M11.55M
Deferred Tax Liabilities0001.05M0000000000000000
Other Non-Current Liabilities5.62M08.79M12.23M13.44M9.24M10.92M72.41M11.64M11.54M42.02M27.64M46K000133K133K134K133K
Total Liabilities35.88M34.44M32.77M36.04M37.93M32.84M34.25M99.07M38.33M41.58M68.11M59.45M31.03M36.49M36.99M42.79M42.06M45.54M57.58M50.64M
Total Debt11.9M3.5M4.35M5.25M6.07M6.88M7.87M8.38M9.13M9.84M10.48M11.14M11.77M12.41M11.96M12.57M13.03M13.44M14.38M14.46M
Net Debt-19.19M-26.88M-25.8M-13.16M-35.88M-11.78M-65.89M-28.62M-26.2M-35.24M-13.67M-124.57M-58.66M-78.41M-66.71M-68.77M-73.41M-57.73M-90.19M-172.36M
Debt / Equity1.05x0.11x0.14x0.10x0.08x0.07x0.07x-0.18x0.15x0.18x0.12x0.21x0.18x0.14x0.12x0.11x0.10x0.09x0.08x
Debt / EBITDA--------------------
Net Debt / EBITDA--------------------
Interest Coverage--------------------
Total Equity11.31M31.88M31.79M53.55M71.83M101.87M116.44M-28.97M50.1M67.23M59.8M92.08M54.82M69.64M84.75M103.9M122.01M136.98M152.89M184.73M
Equity Growth %-84.26%-68.7%-72.7%284.81%43.39%51.52%94.74%-131.47%-8.62%-3.46%-29.44%-11.38%-55.07%-49.16%-44.57%-43.76%-43.78%-18.89%-21.69%-16.05%
Book Value per Share1.083.063.065.166.939.8413.37-4.617.9910.733.843.701.261.611.982.432.853.213.604.36
Total Shareholders' Equity11.31M31.88M31.79M53.55M71.83M101.87M116.44M-28.97M50.1M67.23M59.8M92.08M54.82M69.64M84.75M103.9M122.01M136.98M152.89M184.73M
Common Stock9K9K9K9K9K9K9K8K8K8K7K7K4K4K4K4K4K4K4K4K
Retained Earnings-688.61M-666.75M-665.24M-642.2M-622.32M-590.78M-574.92M-618.01M-535.86M-516.6M-521.66M-486.8M-458.9M-440.86M-422.07M-399.12M-377.23M-358.61M-338.69M-303.07M
Treasury Stock00000000000000000000
Accumulated OCI437K437K438K468K455K420K447K451K577K494K476K545K497K497K499K401K159K50K204K452K
Minority Interest00000000000000000000